FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Melrose Industries Plc appoints Chris Grigg as Non-Executive Director and Chair Designate

Melrose Industries plc appoints Chris Grigg as Non-Executive Director and Chair designate, bringing vast experience from roles in finance and infrastructure...

Whitbread PLC Q1 Trading Update: Sales Growth and Positive Outlook

Whitbread PLC (LON:WTB) Q1 trading update reveals 1% growth in total sales to £739m, driven by UK and Germany progress. CEO remains confident in full-year outlook...

AstraZeneca’s Imfinzi plus chemotherapy approved in the US for endometrial cancer

AstraZeneca's Imfinzi gains FDA approval for endometrial cancer treatment. Results show significant benefits for patients with dMMR disease...

Hikma enhances Injectables pipeline and manufacturing capabilities with Xellia acquisition

Hikma Pharmaceuticals PLC announces agreement to acquire parts of Xellia Pharmaceuticals' US business, expanding its injectables portfolio and manufacturing capabilities...

Kingfisher plc appoints Bhavesh Mistry as its new Chief Financial Officer

Kingfisher plc (LON:KGF) appoints Bhavesh Mistry as new Chief Financial Officer, succeeding Bernard Bot. Mistry brings extensive finance and retail experience to the role...

Tesco PLC reiterate FY guidance, with sales trends in line with expectations

Tesco plc (LON:TSCO) reports Q1 Trading Statement 2024/25, showcasing market share growth and volume increases. CEO Ken Murphy highlights company achievements...

Marathon Oil Corporation Share Price Target ‘$33.76’, now 19.0% Upside Potential

Marathon Oil Corporation which can be found using ticker (MRO) now have 19 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low..

Halma Plc achieves record profit for the 21st consecutive year

Halma plc (LON:HLMA) has released its full year results for the year ending 31 March 2024. Explore the financial details and dividend information here...

St. James’s Place appoints Caroline Waddington as Chief Financial Officer

Caroline Waddington appointed as Chief Financial Officer of St. James's Place plc. A seasoned professional with extensive expertise in financial services...

Legal & General sets out refreshed strategy and financial targets in Capital Markets event

Legal & General Group Plc (LON:LGEN) unveils a strategic plan for sustainable growth, enhanced returns, and a sharper focus on core divisions. CEO António Simões outlines the vision at a..

SEGRO Plc hosting Investor & Analyst Event today on “Defining the Urban Warehouse Opportunity”

Join SEGRO plc at the Investor & Analyst Event on "Defining the Urban Warehouse Opportunity" in London. Learn about their unique urban assets and market-leading platform. CEO David Sleath will..

GSK starts appeal process of recent Delaware Daubert decision

GSK seeks appeal of recent Daubert ruling in Zantac litigation in Delaware Superior Court. Scientific consensus disputes claim of increased cancer risk...

GSK’s Arexvy RSV vaccine approved for adults 50-59 at risk of LRTD

GSK secures FDA approval for Arexvy in adults aged 50-59 at increased risk for RSV-LRTD. Clinical development ongoing, expanding vaccine benefits globally...

Marathon Oil Corporation Share Price Target ‘$34.00’, now 21.9% Upside Potential

Marathon Oil Corporation with ticker code (MRO) have now 18 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $45.00..

Smiths Group plc 25.9% potential upside indicated by Jefferies

Smiths Group plc with ticker (LON:SMIN) now has a potential upside of 25.9% according to Jefferies.SMIN.LJefferies set a target price of 2,180 GBX for the company, which when compared to..

Anglo American plc 26.3% potential upside indicated by Citigroup

Anglo American plc with ticker (LON:AAL) now has a potential upside of 26.3% according to Citigroup.AAL.LCitigroup set a target price of 3,000 GBX for the company, which when compared to..

Fresnillo Plc 39.4% potential upside indicated by JP Morgan

Fresnillo Plc with ticker (LON:FRES) now has a potential upside of 39.4% according to JP Morgan.FRES.LJP Morgan set a target price of 800 GBX for the company, which when compared..

Weir Group PLC 24.5% potential upside indicated by Berenberg Bank

Weir Group PLC with ticker (LON:WEIR) now has a potential upside of 24.5% according to Berenberg Bank.WEIR.LBerenberg Bank set a target price of 2,600 GBX for the company, which when..

Sage Group PLC -7.4% potential downside indicated by Canaccord Genuity

Sage Group PLC with ticker (LON:SGE) now has a potential downside of -7.4% according to Canaccord Genuity.SGE.LCanaccord Genuity set a target price of 970 GBX for the company, which when..

Intertek Group plc 5.2% potential upside indicated by RBC Capital Markets

Intertek Group plc with ticker (LON:ITRK) now has a potential upside of 5.2% according to RBC Capital Markets.ITRK.LRBC Capital Markets set a target price of 5,200 GBX for the company,..

Search

Funds

FTSE 100

Melrose Industries Plc appoints Chris Grigg as Non-Executive Director and Chair Designate

Melrose Industries plc appoints Chris Grigg as Non-Executive Director and Chair designate, bringing vast experience from roles in finance and infrastructure...

Whitbread PLC Q1 Trading Update: Sales Growth and Positive Outlook

Whitbread PLC (LON:WTB) Q1 trading update reveals 1% growth in total sales to £739m, driven by UK and Germany progress. CEO remains confident in full-year outlook...

AstraZeneca’s Imfinzi plus chemotherapy approved in the US for endometrial cancer

AstraZeneca's Imfinzi gains FDA approval for endometrial cancer treatment. Results show significant benefits for patients with dMMR disease...

Hikma enhances Injectables pipeline and manufacturing capabilities with Xellia acquisition

Hikma Pharmaceuticals PLC announces agreement to acquire parts of Xellia Pharmaceuticals' US business, expanding its injectables portfolio and manufacturing capabilities...

Kingfisher plc appoints Bhavesh Mistry as its new Chief Financial Officer

Kingfisher plc (LON:KGF) appoints Bhavesh Mistry as new Chief Financial Officer, succeeding Bernard Bot. Mistry brings extensive finance and retail experience to the role...

Tesco PLC reiterate FY guidance, with sales trends in line with expectations

Tesco plc (LON:TSCO) reports Q1 Trading Statement 2024/25, showcasing market share growth and volume increases. CEO Ken Murphy highlights company achievements...

Halma Plc achieves record profit for the 21st consecutive year

Halma plc (LON:HLMA) has released its full year results for the year ending 31 March 2024. Explore the financial details and dividend information here...

St. James’s Place appoints Caroline Waddington as Chief Financial Officer

Caroline Waddington appointed as Chief Financial Officer of St. James's Place plc. A seasoned professional with extensive expertise in financial services...

Legal & General sets out refreshed strategy and financial targets in Capital Markets event

Legal & General Group Plc (LON:LGEN) unveils a strategic plan for sustainable growth, enhanced returns, and a sharper focus on core divisions. CEO António Simões outlines the vision at a Capital Markets Event...

SEGRO Plc hosting Investor & Analyst Event today on “Defining the Urban Warehouse Opportunity”

Join SEGRO plc at the Investor & Analyst Event on "Defining the Urban Warehouse Opportunity" in London. Learn about their unique urban assets and market-leading platform. CEO David Sleath will kick off the event with insightful presentations and panels...

GSK starts appeal process of recent Delaware Daubert decision

GSK seeks appeal of recent Daubert ruling in Zantac litigation in Delaware Superior Court. Scientific consensus disputes claim of increased cancer risk...

GSK’s Arexvy RSV vaccine approved for adults 50-59 at risk of LRTD

GSK secures FDA approval for Arexvy in adults aged 50-59 at increased risk for RSV-LRTD. Clinical development ongoing, expanding vaccine benefits globally...
Search

Funds

FTSE 100

FTSE 100

Funds